Professional Documents
Culture Documents
D. Setyowireni
RSUP Dr. Sardjito
Introduction
Oxygen Delivery =
[Oxygen Content] x Flow
Glucose Delivery
Insulin sensitive
Glucose transporter
O2 diffusion
Hypoxic
Anemic
Ischemic
Shock
Glucose
ATP
Lack of ATP = Shock
Glycopenic
Shock
HEMOGLOBIN
PRELOAD
OXYGEN SAT
CONTRACTILITY
AFTERLOAD
HEART RATE
OXYGEN CONTENT
STROKE VOLUME
CARDIAC OUTPUT
OXYGEN DELIVERY
Oxygen Delivery
Stages of Shock
Compensated
Uncompensated
Irreversible
BARORECEPTOR
MAP
HUMORAL
CATECHOLAMIN
MAP
CHEMORECEPTOR
ACIDOSIS
AUTO
TRANSFUSION
MAP
TEK. HIDROSTATIK
RESORPSI CAIRAN
INTERSTISIIL
VASOLIDATATION
HR, CO, BP
RENINANGIOTENSIN
ANGIOTENSIN
VASOCONSTRICTION
HR, CO, BP
Hemodynamic Response to
Hemorrhage
Vasc Resistance
% of
Control
100
Blood Pressure
Cardiac Output
25%
50%
% Plasma Loss
CLINICAL SIGNS
COMPENSATED
Tachycardia
Skin perfusion
MAP, blood pressure
DECOMPENSATED
Decreased conssiousness
Decreased urine output
Metabolic acidosis
Hypotension
Fluid Resuscitation
HR/SBP
HR
CR
BP
(-) 40cc/kg
(-) 60cc/kg
70
60
50
40
Tachycardia
30
Eucardia
20
10
0
Sepsis
CAPILLARY REFILL
Patient I
5 African American male who had been admitted 3 days ago with fever, tachycardia to 160s
He has had no urine output in 12 hours
A Condition C was called for increasing respiratory distress
Patient was breathing in the 50s, tachycardic to the 160s, febrile and with a red rash seen all over his body.
80cc/kg of fluid was pushed and he was transferred to the PICU
Patient B
Patient F
Preload
?
Inotropy
Shock
MAP = (SV x HR) x SVR
Afterload
?
What types of shock will affect each of the cardiac parameters?
Hypovolemic
Hemorrhage
Anemia
Cardiogenic
CHF
ACS
Dysrhythmia
Valve Dz
Cardiac tamponade
Distributive
Sepsis
Anaphylactic
Neurologic
Obat-obatan
Obstructive
Aortic valve stenosis
Kardiomioati
Preload
Shock
Inotropy
Afterload
Hypovolemic Cardiogenic
Distributive Obstructive
Low CVP
High CVP
Low CVP
Low CVP
Low CO
Low CO
HIgh CO
Low CO
High SVR
High SVR
Low SVR
+/- SVR
MANAGEMENT
Management-General (cont)
Airway
If not protected or unable to be maintained,
intubate.
Breathing
Always give 100% oxygen to start
Sat monitor
Circulation
Establish IV access rapidly
CR monitor and frequent BP
Management-General (cont)
Laboratory studies:
ABG
Blood sugar
Electrolytes
CBC
PT/PTT
Type and cross
Cultures
Management
Volume Expansion
Optimize preload
NS or RL
Except for myocardial failure use 1020cc/kg aliquots q 2-10 minutes
At 40-60cc/kg reassess and consider:
ongoing losses, adrenal, intestinal
ischemia, obstructive shock. Get CXR.
Consider colloid
Further fluid therapy guided by response,
labs, possibly CVP, CXR
10
9
8
7
6
5
4
3
2
1
1 Hour
2 Hours
3 hours
50%
40%
30%
20%
10%
0%
RL
NS
Colloid
Evaluate MAP-CVP
Inotropes / vasodilators
are required
Kluckow et al J Pediatr 1996)
Management - Cardiotonics II
Epinephrine
0.05-1.5 ug/kg/min
increase HR, SVR,
contractility
End point: adequate BP;
acceptable tachycardia
Norepinephrine
0.05-1.0 ug/kg/min
Increase SVR
End point: adequate BP
Dopamine
2-20 ug/kg/min
Lower doses,
increases renal and
splanchnic blood flow,
& contractility. Higher
doses increases HR
and SVR
End Point: Improved
perfusion, BP, Urine
Dobutamine
1-20 ug/kg/min
increases
contractility, may
reduce SVR, PVR
End Point: Improved
perfusion, may
decrease BP
Prostaglandin E-1
0.05-0.1 ug/kg/min
maintains patency of
ductus
Fluid
resuscitation +
Dobutamine/
Dopamine is
more likely to
increase SVC
flow than
Dobutamine/
Dopamine alone
More fluid
Vasodilator
Inotrope
Stroke
Volume
Volume bolus
70%
SVCO2
Final Thoughts